STAA· Health Care› Medical Instruments & Supplies

STAAR Surgical Company

Stage 4 · Declining · week 5

As of Oct 22, 2026, STAAR Surgical is in Stage 4, the downtrend phase, now in week 5 (since Sep 22, 2026). It closed at $22.49, 32.5% below its 52-week high and below its 200-day average, which is falling.

$22.49

+4.07% today

$1.1B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is STAA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 30w

S4 34w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 30w → S1 6w → S2 8w → S3 12w → S4 34w → S1 9w → S4 3w → S1 3w → S2 10w → S3 13w → S4 10w → S1 5w → S2 10w → S3 8w → S4 4w current

Total tracked: 166 weeks across 15 stage runs.

STAA among Medical Instruments & Supplies30th of 51 by relative strength

All 51 →

Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	PLSEPulse Biosciences, Inc	Stage 2 · wk 34	98	+1.3%
2	PDEXPro-Dex, Inc.	Stage 2 · wk 36	97	−13.3%
3	HBIOHarvard Bioscience, Inc.	Stage 2 · wk 11	95	+3.6%
4	ATRCAtriCure, Inc.	Stage 2 · wk 10	89	−1.1%
5	WSTWest Pharmaceutical Services, Inc.	Stage 2 · wk 24	82	+4.8%
6	BDXBecton, Dickinson and Company	Stage 2 · wk 11	81	+9.8%
7	ICUIICU Medical, Inc.	Stage 3 · wk 1	81	+3.1%
8	OSUROraSure Technologies, Inc.	Stage 3 · wk 8	75	−4.8%
…30	STAASTAAR Surgical Company	Stage 4 · wk 5	42	+13.6%

vs 52W High

-32.5%

$16.10 lo$33.34 hi

32.5% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 5

1w13w26w

Week 5, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-4.5%

200 DMA: $23.54 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.45x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+13.6%

-3.8%

-9.5%

YTD

-4.7%

-15.7%

Scan Membership

Breakout Watch

Latest: 2024-04-24

7 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 5 · Vol 0.45x

2026-10-21S4

Wk 5 · Vol 0.28x

2026-10-20S4

Wk 5 · Vol 0.66x

2026-10-19S4

Wk 4 · Vol 0.73x

2026-10-16S4

Wk 4 · Vol 0.68x

2026-10-15S4

Wk 4 · Vol 0.66x

2026-10-14S4

Wk 4 · Vol 0.57x

2026-10-13S4

Wk 4 · Vol 0.46x

2026-10-12S4

Wk 3 · Vol 0.60x

2026-10-09S4

Wk 3 · Vol 0.59x

2026-10-08S4

Wk 3 · Vol 0.64x

2026-10-07S4

Wk 3 · Vol 0.77x

Moving averages & range

50 DMA

$22.49

200 DMA

$23.54

52W High

$33.34

52W Low

$16.10

5D Low

$21.27

Resistance levels (recent highs)

20d High

$22.61

60d High

$26.18

120d High

$33.34

250d High

$33.34

Next resistance

+0.5%

to 20d High

P/E (TTM)

281.1

Forward 20.2

ROE

+1.1%

Profit margin +1.1%

Dividend Yield

0.00%

P/B 3.1

STAAR Surgical: quick answers

What stage is STAAR Surgical in?

As of Oct 22, 2026, STAAR Surgical (STAA) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 22, 2026 and is in week 5. What the four stages mean

Is STAAR Surgical in an uptrend?

No. STAAR Surgical is in a Stage 4 downtrend. It trades 4.5% below its 200-day average, which is falling.

How far is STAAR Surgical from its 52-week high?

STAAR Surgical closed at $22.49 on Oct 22, 2026, 32.5% below its 52-week high of $33.34. Its 52-week low is $16.10.

How has STAAR Surgical performed over the past year?

As of Oct 22, 2026, STAAR Surgical is down 15.7% over the past year and down 4.7% so far in 2026.

Which sector and industry is STAAR Surgical in?

STAAR Surgical is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.